Boston Scientific Corporation
Hedge Funds Holdings
Last updated:
Boston Scientific Corporation‘s stocks are currently a part of 651 hedge funds’ portfolios, which represents 57.64% of the total amount of its stocks outstanding. This makes up a total of 829.06M shares of Boston Scientific Corporation. Compared to the previous quarter, the number fell by -34.57% or -437.95M shares fewer. As for the holding position changes, 36.56% (238) of current hedge fund investors increased the number of shares held, 36.1% (235) of current holders sold a part of the shares held, and 10.14% (66) closed the holdings completely. 52 hedge funds are new holders of Boston Scientific Corporation stock in Q2 2022, it is 7.99% of total holders.
Hedge funds holding Boston Scientific (Q3 2017 – Q2 2022)
| Q3 2017 | 538 |
|---|---|
| Q4 2017 | 624 |
| Q1 2018 | 623 |
| Q2 2018 | 661 |
| Q3 2018 | 687 |
| Q4 2018 | 718 |
| Q1 2019 | 772 |
| Q2 2019 | 740 |
| Q3 2019 | 753 |
| Q4 2019 | 830 |
| Q1 2020 | 775 |
| Q2 2020 | 814 |
| Q3 2020 | 820 |
| Q4 2020 | 835 |
| Q1 2021 | 804 |
| Q2 2021 | 841 |
| Q3 2021 | 850 |
| Q4 2021 | 858 |
| Q1 2022 | 865 |
| Q2 2022 | 651 |
Hedge funds changes in Boston Scientific positions (Q3 2017 – Q2 2022)
| Q3 2017 | 38 | 204 | 194 | 41 | 61 |
|---|---|---|---|---|---|
| Q4 2017 | 131 | 212 | 192 | 40 | 49 |
| Q1 2018 | 71 | 198 | 224 | 69 | 61 |
| Q2 2018 | 96 | 221 | 223 | 56 | 65 |
| Q3 2018 | 91 | 233 | 234 | 57 | 72 |
| Q4 2018 | 104 | 258 | 240 | 69 | 47 |
| Q1 2019 | 110 | 299 | 241 | 52 | 70 |
| Q2 2019 | 78 | 276 | 258 | 98 | 30 |
| Q3 2019 | 78 | 261 | 276 | 62 | 76 |
| Q4 2019 | 151 | 293 | 270 | 62 | 54 |
| Q1 2020 | 82 | 286 | 303 | 126 | -22 |
| Q2 2020 | 108 | 346 | 242 | 66 | 52 |
| Q3 2020 | 82 | 317 | 295 | 73 | 53 |
| Q4 2020 | 121 | 328 | 281 | 100 | 5 |
| Q1 2021 | 83 | 285 | 300 | 109 | 27 |
| Q2 2021 | 100 | 295 | 303 | 58 | 85 |
| Q3 2021 | 79 | 332 | 279 | 63 | 97 |
| Q4 2021 | 113 | 285 | 312 | 94 | 54 |
| Q1 2022 | 103 | 337 | 280 | 81 | 64 |
| Q2 2022 | 52 | 238 | 235 | 66 | 60 |
Hedge funds changes in Boston Scientific stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 41,925,000 | 46,337,000 |
|---|---|---|
| Q4 2017 | 54,500,000 | 61,146,000 |
| Q1 2018 | 26,000,078,864,000 | 23,000,066,808,000 |
| Q2 2018 | 3,000,234,674,690 | 136,477,400 |
| Q3 2018 | 232,466,950 | 96,553,000 |
| Q4 2018 | 175,544,578 | 5,000,085,559,294 |
| Q1 2019 | 142,642,476 | 63,813,000 |
| Q2 2019 | 229,231,396 | 127,890,420 |
| Q3 2019 | 236,084,317 | 4,000,142,025,268 |
| Q4 2019 | 187,675,054 | 1,000,176,289,370 |
| Q1 2020 | 172,728,627 | 10,000,206,067,998 |
| Q2 2020 | 207,052,819 | 4,000,357,243,261 |
| Q3 2020 | 4,425,000,144,061,212 | 3,910,000,338,672,765 |
| Q4 2020 | 1,800,000,255,726,925 | 3,226,000,353,830,655 |
| Q1 2021 | 217,110,620 | 450,000,307,256,305 |
| Q2 2021 | 368,975,752 | 390,574,396 |
| Q3 2021 | 305,321,478 | 488,801,569 |
| Q4 2021 | 279,415,160 | 176,000,474,855,208 |
| Q1 2022 | 312,308,000 | 341,836,000 |
| Q2 2022 | 61,129,000 | 133,446,253 |